Skip to main navigation Skip to search Skip to main content

Hemolytic Anemia of Malignancy: A Case Study Involving Signet Ring Cell Metastatic Breast Cancer with Severe Microangiopathic Hemolytic Anemia

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Hemolytic anemia in the setting of malignancy is a rare manifestation of paraneoplastic syndrome with significant morbidity. Here we discuss a case involving metastatic breast cancer presenting with severe hemolytic anemia and renal failure secondary to thrombotic microangiopathy of malignancy. This case discusses the workup for secondary hemolytic anemia, a possible role for therapeutic plasma exchange in this setting, as well the current understanding of the management of microangiopathic hemolytic anemia of malignancy.

    Original languageEnglish
    Pages (from-to)104-108
    Number of pages5
    JournalCase Reports in Oncology
    Volume12
    Issue number1
    DOIs
    StatePublished - Jan 1 2019

    ASJC Scopus Subject Areas

    • Oncology

    Keywords

    • Breast cancer
    • Hemolysis
    • Hemolytic anemia
    • Paraneoplastic
    • Plasma exchange

    Cite this